Vinva Investment Management’s DocuSign DOCU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Sell
24,727
-17,486
-41% -$820K 0.01% 310
2026
Q1
$2.91M Sell
42,213
-526,645
-93% -$26.9M 0.04% 252
2025
Q4
$39.9M Buy
568,858
+422,088
+288% +$29.2M 0.5% 45
2025
Q3
$12.4M Buy
146,770
+133,630
+1,017% +$10.3M 0.24% 103
2025
Q2
$1M Sell
13,140
-5,653
-30% -$457K 0.03% 299
2025
Q1
$1.56M Sell
18,793
-100,912
-84% -$8.84M 0.06% 242
2024
Q4
$11M Sell
119,705
-29,555
-20% -$2.36M 0.42% 50
2024
Q3
$9.2M Buy
149,260
+6,606
+5% +$370K 0.39% 61
2024
Q2
$7.63M Buy
142,654
+38,395
+37% +$2.17M 0.38% 58
2024
Q1
$6.34M Buy
104,259
+95,550
+1,097% +$5.39M 0.36% 61
2023
Q4
$524K Buy
+8,709
New +$399K 0.04% 327
2023
Q3
Sell
-5,297
Closed -$271K 368
2023
Q2
$271K Sell
5,297
-942
-15% -$49.9K 0.02% 353
2023
Q1
$353K Buy
+6,239
New +$372K 0.03% 353

Other funds holding DOCU

Vinva Investment Management's DOCU Position: Q2 2026 in Review

Vinva Investment Management reduced its DocuSign (DOCU) stake by 41% in Q2 2026, selling an estimated $820K and leaving 24,727 shares worth $1.62M. The position accounts for 0.01% of the portfolio, ranked #310.

Vinva Investment Management first reported a position in DOCU in Q1 2023 and has held it in 13 quarters since. The position peaked at $39.9M in Q4 2025. 672 funds tracked by Wall St. Rank hold DOCU as of Q2 2026.

  • Vinva Investment Management held 24,727 shares of DocuSign worth $1.62M as of Q2 2026.
  • Vinva Investment Management sold 17,486 DocuSign shares in Q2 2026, an estimated $820K.
  • DocuSign made up 0.01% of Vinva Investment Management's portfolio in Q2 2026, its #310 holding.
  • Vinva Investment Management first reported a position in DocuSign in Q1 2023 and has held it in 13 quarters since.
  • Vinva Investment Management's DocuSign position peaked at $39.9M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held DocuSign as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.